Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial
重组单克隆抗体siltartoxatug与血浆来源的人破伤风免疫球蛋白治疗破伤风的疗效比较：一项随机、双盲、阳性对照的3期临床试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03791-8
Liang, Zijing; Liu, Si; Guo, Wei; Deng, Zhe; Bin, Wenkai; Yu, Anyong; Hu, Junyan; Wu, Lidong; Li, Zhanfei; Huang, Wei; Li, He; Cheng, Dapeng; Li, Shugui; Guo, Qinghao; Zhang, Dongshan; Yan, Xinming; Wang, Chunlei; Cai, Wenwei; Ding, Banghan; Li, Wenqiang; Li, Xu; Xu, Bin; He, Lei; Ouyang, Yanhong; Zhan, Hong; Wang, Jianwei; Zhao, Yan; Liu, Xinyu; Xiang, Wenxi; Zhang, Meizhuo; Zhang, Zhihua; Ding, Jiyuan; Kuang, Xiaohu; Zheng, Weihong; Liao, Huaxin; Wang, Wanmei; Wang, Chuanlin
